REPEAT -- Revelation Biosciences Inc. Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS-CoV-2; Commencement of Trading as a Public Company
Provided By Globe Newswire
Last update: Jan 13, 2022
-A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed-
-REVTx-99 was tested prior to infection in multiple standard in vitro anti-viral activity assay systems-
Read more at globenewswire.comNASDAQ:REVB (4/25/2025, 8:00:01 PM)
2.92
-0.01 (-0.34%)
NASDAQ:REVBW (4/25/2025, 8:00:01 PM)
0.0108
0 (-28%)
Find more stocks in the Stock Screener
REVB Latest News and Analysis
18 days ago - ChartmillWondering what's happening in today's after-hours session?Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
